Results 41 to 50 of about 29,428 (269)

Validation of the VT‐LVAD score for prediction of late VAs in LVAD recipients [PDF]

Journal of Cardiovascular Electrophysiology, 2020
AbstractObjectivesThis study sought to validate the performance of the VT‐LVAD risk model in predicting late ventricular arrhythmias (VAs) in patients after left ventricular assist device (LVAD) implantation.BackgroundThe need for implantable cardioverter‐defibrillator (ICD)‐implantation in LVAD recipients is not well studied. A better selection of the
Darma, Angeliki, Arya, Arash, Dagres, Nikolaos, Kuehl, Michael, Hindricks, Gerhard, Eifert, Sandra, Saeed, Diyar, Borger, Michael, Martins, Raphael P., Leclercq, Christophe, Galand, Vincent   +10 more
openaire   +3 more sources

Heart-Failing Jehovah's Witness Patient Successfully Treated by Minimally Invasive LVAD Implantation without Any Blood Transfusions

The Thoracic & Cardiovascular Surgeon Reports, 2015
Left ventricular assist device (LVAD) implantation without the use of any blood products is considered as a challenge. We present a 48-year-old patient (175 cm, 75 kg, body mass index 24.5 kg/m2) who was admitted to our clinic due to end-stage heart ...
Jasmin S. Hanke, Murat Avsar, Axel Haverich, Jan D. Schmitto   +3 more
doaj   +1 more source

Changes in eligibility for a subcutaneous cardioverter-defibrillator after implantation of a left ventricular assist device-A prospective analysis.

PLoS ONE, 2023
BackgroundThe number of left ventricular assist devices (LVADs) implanted in patients with end-stage heart failure is increasing. In this patient cohort, subcutaneous implantable cardioverter defibrillators (S-ICDs) could be a promising alternative to ...
Christos Zormpas, Johanna Mueller-Leisse, Stephan Hohmann, Jörg Eiringhaus, Henrike Aenne Katrin Hillmann, Jan D Schmitto, Christian Veltmann, David Duncker   +7 more
doaj   +1 more source

Linear tubular switched reluctance motor for heart assistance circulatory: Analytical and finite element modeling [PDF]

, 2011
A linear tubular switched reluctance motor is presented. This actuator is devoted to be used as a left ventricular assist device (LVAD). In order to avoid thrombosis, this actuator includes pump and valve functions. By using a St. Jude Medical mechanical
Leprince, Pascal, Llibre, Jean-François, Martinez, Nicolas, Nogarède, Bertrand   +3 more
core   +3 more sources

Impact of Diabetes and Glycemia on Cardiac Improvement and Adverse Events Following Mechanical Circulatory Support

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background Type 2 diabetes is prevalent in cardiovascular disease and contributes to excess morbidity and mortality. We sought to investigate the effect of glycemia on functional cardiac improvement, morbidity, and mortality in durable left ventricular ...
Christos P. Kyriakopoulos, Iosif Taleb, Eleni Tseliou, Konstantinos Sideris, Rana Hamouche, Eleni Maneta, Marisca Nelson, Ethan Krauspe, Sean Selko, Joseph R. Visker, Elizabeth Dranow, Matthew L. Goodwin, Rami Alharethi, Omar Wever‐Pinzon, James C. Fang, Josef Stehlik, Craig H. Selzman, Thomas C. Hanff, Stavros G. Drakos   +18 more
doaj   +1 more source

Patient-specific, echocardiography compatible flow loop model of aortic valve regurgitation in the setting of a mechanical assist device

Frontiers in Cardiovascular Medicine, 2023
BackgroundAortic regurgitation (AR) occurs commonly in patients with continuous-flow left ventricular assist devices (LVAD). No gold standard is available to assess AR severity in this setting.
Mahwash Kassi, Stefano Filippini, Eleonora Avenatti, Susan Xu, Susan Xu, Kinan Carlos El-Tallawi, Clara I. Angulo, Marija Vukicevic, Marija Vukicevic, Stephen H. Little   +9 more
doaj   +1 more source

HFA of the ESC position paper on the management of LVAD‐supported patients for the non‐LVAD specialist healthcare provider Part 3: at the hospital and discharge

ESC Heart Failure, 2021
The growing population of left ventricular assist device (LVAD)‐supported patients increases the probability of an LVAD‐ supported patient hospitalized in the internal or surgical wards with certain expected device related, and patient‐device interaction
Finn Gustafsson, Binyamin Ben Avraham, Ovidiu Chioncel, Tal Hasin, Avishai Grupper, Aviv Shaul, Sanemn Nalbantgil, Yoav Hammer, Wilfried Mullens, Laurens F. Tops, Jeremy Elliston, Steven Tsui, Davor Milicic, Johann Altenberger, Miriam Abuhazira, Stephan Winnik, Jacob Lavee, Massimo Francesco Piepoli, Lorrena Hill, Righab Hamdan, Arjang Ruhparwar, Stefan Anker, Marisa Generosa Crespo‐Leiro, Andrew J.S. Coats, Gerasimos Filippatos, Marco Metra, Giuseppe Rosano, Petar Seferovic, Frank Ruschitzka, Stamatis Adamopoulos, Yaron Barac, Nicolaas De Jonge, Maria Frigerio, Eva Goncalvesova, Israel Gotsman, Osnat Itzhaki Ben Zadok, Piotr Ponikowski, Luciano Potena, Arsen Ristic, Tiny Jaarsma, Tuvia Ben Gal   +40 more
doaj   +1 more source

Mechanistic assessment and ablation of left ventricular assist device related ventricular tachycardia in patients with severe heart failure

Frontiers in Physiology, 2023
Aims: Left-ventricular-assist-devices (lvad) are an established treatment for patients with severe heart failure with reduced ejection fraction (HF) and reduce mortality.
Felix Hohendanner, Felix Hohendanner, Felix Hohendanner, Matthias Bock, Julian Keznickl-Pulst, Vesna Furundzija, Vesna Furundzija, Sebastian Scholz, Doreen Schöppenthau, Doreen Schöppenthau, Yuriy Hrytsyna, Yuriy Hrytsyna, Volkmar Falk, Volkmar Falk, Volkmar Falk, Volkmar Falk, Burkert Pieske, Gerhard Hindricks, Gerhard Hindricks, Evgenij Potapov, Evgenij Potapov, Jin-Hong Gerds-Li, Jin-Hong Gerds-Li   +22 more
doaj   +1 more source

Predicting Bleeding and Thrombosis Complications in Patients with Continuous Flow Left Ventricular Assist Devices [PDF]

, 2020
Background: Left ventricular assist device (LVAD) therapy has been proven to relieve heart failure symptoms and improve survival, but is not devoid of bleeding and/or thrombotic complications.
Cook, Aaron, Kuan, William, McCann, Justin McCann, Parli, Sara, Schadler, Aric, Sieg, Adam, Zacholski, Kyle   +6 more
core   +1 more source

Socio‐economic inequalities and heart failure morbidity and mortality: A systematic review and data synthesis

ESC Heart Failure, Volume 12, Issue 2, Page 927-941, April 2025.
Abstract Socio‐economic status (SES) has been associated with incident and prevalent heart failure (HF), as well as its morbidity and mortality. However, the precise nature of the relationship between SES and HF remains unclear due to inconsistent data. This study aims to provide a comprehensive assessment and data synthesis of the relationship between
Abdul Shakoor, Willemijn A. van Maarschalkerwaart, Jeroen Schaap, Rudolf A. de Boer, Nicolas M. van Mieghem, Eric H. Boersma, Loek van Heerebeek, Jasper J. Brugts, Robert M.A. van der Boon   +8 more
wiley   +1 more source